Melanoma/Skin Cancer

Top Story

Edoxaban noninferior to warfarin for cancer, VTE

July 29, 2016

Edoxaban may more effectively treat venous thromboembolism and produce less clinically relevant bleeding than warfarin in patients with cancer, according to a subgroup analysis of a randomized, double blind, double-dummy, open-label trial.

VTE is a common adverse event in patients with cancer. Direct oral anticoagulants, such as edoxaban (Savaysa, Daiichi Sankyo), have been proven noninferior to conventional anticoagulation treatments.

In the Journals Plus

Melanoma screening increases detection with little impact on use of surgery, specialist referrals

July 28, 2016
Melanoma screening in the community medical setting increased melanoma diagnoses rates, but did not result in an upsurge of skin surgeries or dermatology office visits…
In the Journals Plus

Opinions on prognosis often discordant between patients and their oncologists

July 27, 2016
Patients with advanced cancers frequently interpreted their prognoses differently from their oncologists, according to the results of a cross-sectional study published…
In the Journals

Melanoma in situ incidences increase at faster rate than invasive melanoma

July 27, 2016
Incidence of melanoma in situ increased at a faster rate than invasive melanoma, with the two melanomas displaying epidemiological and clinical differences, according to…
CME

The Patient with Castration-resistant Prostate Cancer

No commercial support for this activity.

Castration-resistant prostate cancer (CRPC) is a heterogeneous condition that encompasses a continuum of disease…
More »
Video
Meeting News Coverage

VIDEO: Speaker discusses practical issues of melanoma molecular testing

April 8, 2016
More »
Featured
2016 ASCO Annual Meeting

2016 ASCO Annual Meeting

CME

Optimizing the Use of Targeted Therapy in Advanced Melanoma: Where We Are and Where We Are Going

This activity is supported by an educational grant from Genentech.

Melanoma is the deadliest form of skin cancer. Historically, treatment options have been limited for patients with…
More »
In the Journals Plus

Edoxaban noninferior to warfarin for cancer, VTE

July 29, 2016
Edoxaban may more effectively treat venous thromboembolism and produce less clinically relevant bleeding than warfarin in patients with cancer…

In the Journals Plus

Melanoma screening increases detection with little impact on use of surgery, specialist referrals

July 28, 2016
Melanoma screening in the community medical setting increased melanoma diagnoses rates, but did not result in an upsurge of skin surgeries or…

In the Journals Plus

Opinions on prognosis often discordant between patients and their oncologists

July 27, 2016
Patients with advanced cancers frequently interpreted their prognoses differently from their oncologists, according to the results of a…

In the Journals

Melanoma in situ incidences increase at faster rate than invasive melanoma

July 27, 2016
Incidence of melanoma in situ increased at a faster rate than invasive melanoma, with the two melanomas displaying epidemiological and clinical…

In the Journals Plus

Local peripheral therapies improve efficacy of ipilimumab for melanoma

July 27, 2016
The addition of ipilimumab to local peripheral treatments significantly extended OS in patients with melanoma, according to the results of a…

In the Journals

USPSTF finds insufficient evidence in favor of screening for skin cancer

July 26, 2016
There is not sufficient evidence to recommend visual skin examination by a clinician in screening for skin cancer in asymptomatic adults, the U.S…

In the Journals Plus

Second malignancies, death common among cancer survivors

July 25, 2016
Approximately one in 12 patients with a common primary tumor were diagnosed with a second primary malignancy between 1992 and 2008, according to…

Fox Chase Cancer Center announces staff appointments

July 25, 2016
Fox Chase Cancer Center announced three staff appointments. Rajeswari Nagarathinam , MD, has joined the department of…

In the Journals Plus

Delirium frequently underdiagnosed in patients with advanced cancers

July 25, 2016
Delirium occurs frequently but appears underdiagnosed in patients with advanced cancer who presented in the ED, according to the results of a…

What cancer screenings are recommended for women?

July 22, 2016
Women have a 37% chance of developing invasive cancer during their lifetime, and a 19% chance of dying of cancer, according to American Cancer…

More Headlines »
morganatic-roan
morganatic-roan